Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA NRF2-AS1 increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 24/January/2019, 8.17 pm